Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Janux Therapeutics (JANX) Interest Expenses (2020)

Historic Interest Expenses for Janux Therapeutics (JANX) over the last 1 years, with Q2 2020 value amounting to $109000.0.

  • Janux Therapeutics' Interest Expenses changed N/A to $109000.0 in Q2 2020 from the same period last year, while for Mar 2021 it was $109000.0, marking a year-over-year change of. This contributed to the annual value of $206000.0 for FY2020, which is N/A changed from last year.
  • As of Q2 2020, Janux Therapeutics' Interest Expenses stood at $109000.0.
  • Janux Therapeutics' 5-year Interest Expenses high stood at $109000.0 for Q2 2020, and its period low was $109000.0 during Q2 2020.